Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma

Table 1 Characteristics of 50 patients with nasopharyngeal carcinoma

Characteristics		Overall		CD80/86(+)
		No.	%	No.	%
Age, years
	Range	38–83		38–78
	Median	50		46
	Mean	53		50
Sex
	Male	42	84	10	91
	Female	8	16	1	9
Pathology (WHO classification)
	Type I	--		--
	Type II	35	70	6	55
	Type III	15	30	5	45
T Stage (1997 AJCC)
	T1 or T2	32	64	9	82
	T3 or T4	18	36	2	18
N Stage (1997AJCC)
	N0 or N1	24	48	6	55
	N2	17	34	3	27
	N3	9	18	2	18
Overall Stage (1997 AJCC)
	I	5	10	3	27
	II	10	20	3	27
	III	13	26	2	18
	IV	22	44	3	27
Treatment
	Radiotherapy alone	8	16	2	18
	Concurrent Chemoradiotherapy	42	84	9	82
Status
	Death	16	32	0	0
	Alive	34	68	11	100

Abbreviations: WHO, World Health Organization; AJCC, American Joint Committee on Cancer; FDRC, Follicular Dendritic Reticulum Cells

ISSN: 1471-2407